US Patent Issued to Medicenna Therapeutics on April 15 for "IL-4-fusion formulations for treatment of central nervous system (CNS) tumors" (Canadian Inventor)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,735, issued on April 15, was assigned to Medicenna Therapeutics Inc. (Toronto).

"IL-4-fusion formulations for treatment of central nervous system (CNS) tumors" was invented by Fahar Merchant (Vancouver, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for the treatment of a central nervous system (CNS) tumor in a subject comprising administering and IL-4 targeted cargo protein formulated in an artificial cerebral spinal fluid formulation. The present invention also provides formulations and methods for administration along with a surrogate tracer for monitoring."

The patent was filed on Oct. 10, 2018, unde...